# Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184

> **NCT07636928** · PHASE1 · RECRUITING · sponsor: **ViiV Healthcare** · enrollment: 9 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** VH4524184
- **DRUG:** [14C]VH4524184 microdose
- **DRUG:** [14C]VH4524184

## Key facts

- **NCT ID:** NCT07636928
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-04
- **Primary completion:** 2026-08-20
- **Final completion:** 2026-08-20
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2026-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07636928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07636928, "Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07636928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*